About BeamLine Diagnostics
BeamLine Diagnostics is a company based in London (United Kingdom) founded in 2015 by Katie Oliver. It operates as a B2B. BeamLine Diagnostics has raised $1.08 million across 2 funding rounds from investors including Angels in MedCity, Angel Academe and LCIF. The company has 7 employees as of March 31, 2020. BeamLine Diagnostics operates in a competitive market with competitors including PAVmed, Cyted, Previse, Lucid Diagnostics and CapNostics, among others.
- Headquarter London, United Kingdom
- Employees 7 as on 31 Mar, 2020
- Founders Katie Oliver
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Beamline Diagnostics Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.08 M (USD)
in 2 rounds
-
Latest Funding Round
$837.86 K (USD), Seed
Jun 06, 2017
-
Investors
Angels in MedCity
& 3 more
-
Employee Count
7
as on Mar 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BeamLine Diagnostics
BeamLine Diagnostics has successfully raised a total of $1.08M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $837.86 thousand completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BeamLine Diagnostics
BeamLine Diagnostics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Angels in MedCity, Angel Academe and LCIF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Angel Academe is focused on supporting female founders through investments.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on digital, science, and technology sectors
|
Locked | Locked | Locked |
Investor details for BeamLine Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BeamLine Diagnostics
Investment portfolio details for BeamLine Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BeamLine Diagnostics
Detailed financials for BeamLine Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Beamline Diagnostics Comparisons
Peer comparison for BeamLine Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BeamLine Diagnostics
BeamLine Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PAVmed, Cyted, Previse, Lucid Diagnostics and CapNostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of medical devices and biomarkers to detect various diseases
|
|
| Locked | Locked | Locked |
Non-endoscopic diagnostics for early gastrointestinal disease detection are developed.
|
|
| Locked | Locked | Locked |
Cancer detection and prevention solutions are developed by Previse.
|
|
| Locked | Locked | Locked |
Diagnostic kits for esophageal cancer biomarkers are developed.
|
|
| Locked | Locked | Locked |
FDA-cleared swallowable device is used for non-endoscopic GI screening.
|
Detailed competitors of BeamLine Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Beamline Diagnostics
Complete news archive for BeamLine Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BeamLine Diagnostics
BeamLine Diagnostics was founded in 2015 and raised its 1st funding round 1 year after it was founded.
BeamLine Diagnostics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
BeamLine Diagnostics is a funded company, having raised a total of $1.08M across 2 funding rounds to date.
As of Mar 31, 2020, the latest employee count at BeamLine Diagnostics is 7.
BeamLine Diagnostics offers bedside pre-screening technology solutions for cancer detection through providing healthcare solutions, developing medical devices, offering diagnostic solutions, and cancer screening. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
BeamLine Diagnostics's top competitors include Lucid Diagnostics, PAVmed and Previse.
BeamLine Diagnostics has 4 investors. Key investors include Angels in MedCity, Angel Academe, LCIF, and Deepbridge Capital.